Inquire Before Buying
Speak to an Analyst
Request Brochure
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More- Home
- |
- Press Release
- |
- Japan Generic Drug Market
Japan Generic Drug Market to Reach US$ 21.4 Billion by 2032, Driven by Rising Healthcare Expenditure
June 29, 2023
| Healthcare
According to the latest report by IMARC Group, titled “Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” the Japan generic drug market size reached US$ 11.5 Billion in 2023. Generic drugs refer to pharmaceutical products that are bioequivalent to brand-name drugs in terms of strength, dosage form, route of administration, safety, efficacy, and quality. They are developed and marketed after the patent protection of the original brand-name drug expires. Generic drugs provide an affordable alternative to their brand-name counterparts, offering the same therapeutic benefits at a lower cost. In order to produce a generic drug, manufacturers demonstrate that it contains the same active ingredient(s) as the brand-name drug and meets strict quality standards set by regulatory authorities. The manufacturing facilities and processes for generic drugs must adhere to Good Manufacturing Practices (GMP) to ensure consistency, safety, and effectiveness. Generic drugs undergo a rigorous approval process, including comprehensive testing and evaluation to establish their bioequivalence to the brand-name drug, which means that they are absorbed and distributed in the body at similar rates, thus leading to comparable therapeutic outcomes. Moreover, generic drugs enhance market competition, which can drive down prices and improve overall healthcare affordability.
Japan Generic Drug Market Trends:
The increasing demand for affordable medicines represents one of the key factors driving the growth of the market across Japan. In addition to this, healthcare providers and consumers becoming more familiar with their benefits due to the increasing availability of more generic drug options is leading to higher adoption rates, thereby contributing to the market growth. The market is also driven by the Government of Japan actively promoting the use of generic drugs to control healthcare costs. The implementation of policies and initiatives to encourage the prescribing and consumption of generic drugs is acting as a major growth-inducing factor. This includes measures, such as pricing regulations, incentives for physicians, and public awareness campaigns, which are fueling the growth of the market. In line with this, the increasing demand for pharmaceutical products, along with the steadily expanding geriatric population base is driving the demand for generic drugs, which is contributing to the growth of the market. The increasing preference for generic drugs that offer cost-effective alternatives to brand-name drugs due to their affordability is propelling the market growth. In addition to this, the rising healthcare expenditures, along with the increasing demand for cost-effective solutions to manage healthcare costs without compromising the quality of healthcare services are facilitating the growth of the market across the country. Looking forward, the market value is projected to reach US$ 21.4 Billion by 2032, expanding at a CAGR of 6.9% during 2024-2032.
Market Summary:
- The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the key players operating in the industry.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More